| Financial Year |
March 31 2023 |
| Monetary Funds |
44,844,204.56 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
20,225,067.82 |
| Accounts Receivable |
537,525,915.19 |
| Advances to Suppliers |
34,058,579.74 |
| Other Receivables |
24,397,253.67 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
305,202,243.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,312,709.47 |
| Total Current Assets |
1,286,343,008.50 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
4,216,101.00 |
| Long-term Equity Investment |
108,735,499.03 |
| Investment Properties |
2,821,611.97 |
| Fixed Assetes |
177,676,610.39 |
| Under-construction Projects |
755,593.81 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,180,283.83 |
| R&D expenses |
2,321,726.30 |
| Goodwill |
170,833,394.56 |
| Long-Term Deferred and Prepaid Expenses |
12,234,961.07 |
| Deferred Income Tax Assets |
99,096,427.79 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
640,975,820.49 |
| Total Assets |
1,927,318,828.99 |
| Short-Term Loans |
234,001,713.40 |
| Trading Financial liabilities |
-- |
| Notes Payable |
13,574,500.00 |
| Accounts Payable |
439,194,441.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
20,227,441.38 |
| Taxes Payable |
5,923,641.45 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
188,482,465.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
132,364,414.90 |
| Other Current Liabilities |
39,453,741.00 |
| Sub-Total of Current Liabilities |
1,176,564,977.40 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
21,581,538.07 |
| Special Payable |
-- |
| Estimatied Liabilities |
4,180,000.00 |
| Deferred Income Tax Liabilities |
1,553,587.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
39,429,875.03 |
| Total Liabilities |
1,215,994,852.43 |
| Paid-In Capital(Or Share Stock) |
381,368,000.00 |
| Capital Surplus |
493,248,432.69 |
| Surplus Reserve |
34,700,882.59 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-200,498,616.85 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
711,323,976.56 |
| Owner's Equity（Stockholder's Equity） |
711,323,976.56 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,927,318,828.99 |
